Activation of mitogen-activated protein kinases by lysophosphatidylcholine- induced mitochondrial reactive oxygen species generation in endothelial cells

American Journal of Pathology

Volumn 168, Issue 5, 2006, Pages 1737-1748

  Watanabe, Nobuo ^a   Zmijewski, Jaroslaw W ^d   Takabe, Wakako ^a,c   Umezu Goto, Makiko ^b   Le Goffe, Claire ^d   Sekine, Azusa ^a   Landar, Aimee ^d   Watanabe, Akira ^a   Aoki, Junken ^b   Arai, Hiroyuki ^b   Kodama, Tatsuhiko ^a   Murphy, Michael P ^e   Kalyanaraman, Raman ^f   Darley Usmar, Victor M ^d   Noguchi, Noriko ^a,g  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g DOSHISHA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA TOCOPHEROL; ANTIMYCIN A1; ANTIOXIDANT; CALCIUM ION; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; DOUBLE STRANDED DNA; EGTAZIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GAMMA TOCOPHEROL; HEME OXYGENASE 1; HYDROGEN PEROXIDE; LIPID; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N,N' BIS(2 HYDROXYBENZYL)ETHYLENEDIAMINE N,N' DIACETIC ACID; OLIGOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; ROTENONE; SMALL INTERFERING RNA; UO 126;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DNA SEQUENCE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSPORT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 33646508129     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050648     Document Type: Article

References (69)

1. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002, 277:48737-48744
2. Steinbrecher UP, Zhang HF, Lougheed M: Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 1990, 9:155-168
3. Noguchi N: Novel insights into the molecular mechanisms of the antiatherosclerotic properties of antioxidants: the alternatives to radical scavenging. Free Radic Biol Med 2002, 33:1480-1489
4. Moellering DR, Levonen AL, Go YM, Patel RP, Dickinson DA, Forman HJ, Darley-Usmar VM: Induction of glutathione synthesis by oxidized low-density lipoprotein and 1-palmitoyl-2-arachidonyl phosphatidylcholine: protection against quinone-mediated oxidative stress. Biochem J 2002, 362:51-59
5. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N: Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 2003, 278:51006-51014
6. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ: Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997, 100:1209-1216
7. Yoshida T, Migita CT: Mechanism of heme degradation by heme oxygenase. J Inorg Biochem 2000, 82:33-41
8. Bergmann SR, Ferguson TB Jr, Sobel BE: Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am J Physiol 1981, 240:H229-H237
9. Takabe W, Kanai Y, Chairoungdua A, Shibata N, Toi S, Kobayashi M, Kodama T, Noguchi N: Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2. Arterioscler Thromb Vasc Biol 2004, 24:1640-1645
10. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Witte ON, Xu Y: Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 2001, 276:41325-41335
11. Lum H, Qiao J, Walter RJ, Huang F, Subbaiah PV, Kim KS, Holian O: Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am J Physiol Heart Circ Physiol 2003, 285:H1786-H1789
12. Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 2001, 293:702-705
13. Ogita T, Tanaka Y, Nakaoka T, Matsuoka R, Kira Y, Nakamura M, Shimizu T, Fujita T: Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages. Am J Physiol 1997, 272:H17-H24
14. Huang YH, Schafer-Elinder L, Wu R, Claesson HE, Frostegard J: Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol 1999, 116:326-331
15. Bektas M, Barak LS, Jolly PS, Liu H, Lynch KR, Lacana E, Suhr KB, Milstien S, Spiegel S: The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner. Biochemistry 2003, 42:12181-12191
16. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K: Proton-sensing G-protein-coupled receptors. Nature 2003, 425:93-98
17. Witte ON, Kabarowski JH, Xu Y, Le LQ, Zhu K: Retraction. Science 307:206, 2005
18. Stoll LL, Oskarsson HJ, Spector AA: Interaction of lysophosphatidylcholine with aortic endothelial cells. Am J Physiol 1992, 262:H1853-H1860
19. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990, 344:160-162
20. Flavahan NA: Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am J Physiol 1993, 264:H722-H727
21. Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y, Akita H, Yokoyama M: Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Circ Res 1992, 71:1410-1421
22. Chaudhuri P, Colles SM, Damron DS, Graham LM: Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain. Arterioscler Thromb Vasc Biol 2003, 23:218-223
23. Inoue N, Takeshita S, Gao D, Ishida T, Kawashima S, Akita H, Tawa R, Sakurai H, Yokoyama M: Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 2001, 155:45-52
24. Murugesan G, Sandhya Rani MR, Gerber CE, Mukhopadhyay C, Ransohoff RM, Chisolm GM, Kottke-Marchant K: Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. J Mol Cell Cardiol 2003, 35:1375-1384
25. Bassa BV, Roh DD, Vaziri ND, Kirschenbaum MA, Kamanna VS: Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways. Am J Physiol 1999, 277:F328-F337
26. Rikitake Y, Kawashima S, Takahashi T, Ueyama T, Ishido S, Inoue N, Hirata K, Yokoyama M: Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine. Am J Physiol Heart Circ Physiol 2001, 281:H266-H274
27. Forman HJ, Torres M, Fukuto J: Redox signaling. Mol Cell Biochem 2002, 234-235:49-62
28. Landar A, Darley-Usmar VM: Nitric oxide and cell signaling: modulation of redox tone and protein modification. Amino Acids 2003, 25:313-321
29. Li JM, Shah AM: Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1014-R1030
30. Lassegue B, Clempus RE: Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R277-R297
31. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T: Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 2000, 20:7311-7318
32. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Dates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790
33. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001, 276:25096-25100
34. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD: Mitochondrial sources of H202 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 2003, 93:573-580
35. Chang SH, Garcia J, Melendez JA, Kilberg MS, Agarwal A: Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem J 2003, 371:877-885
36. Chen K, Thomas SR, Albano A, Murphy MP, Keaney JF Jr: Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling. J Biol Chem 2004, 279:35079-35086
37. Fang Y, Han SI, Mitchell C, Gupta S, Studer E, Grant S, Hylemon PB, Dent P: Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 2004, 40:961-971
38. Bogoyevitch MA, Ng DC, Court NW, Draper KA, Dhillon A, Abas L: Intact mitochondrial electron transport function is essential for signalling by hydrogen peroxide in cardiac myocytes. J Mol Cell Cardiol 2000, 32:1469-1480
39. Kadenbach B: Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim Biophys Acta 2003, 1604:77-94
40. Brookes PS, Levonen AL, Shiva S, Sarti P, Darley-Usmar VM: Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 2002, 33:755-764
41. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS: Calcium ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287:C817-C833
42. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, Murphy MP: Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 2004, 279:47939-47951
43. Yamakawa T, Tanaka S, Yamakawa Y, Kamei J, Numaguchi K, Motley ED, Inagami T, Eguchi S: Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2002, 22:752-758
44. Wolfram Kuhlmann CR, Wiebke Ludders D, Schaefer CA, Kerstin Most A, Backenkohler U, Neumann T, Tillmanns H, Erdogan A: Lysophosphatidylcholine- induced modulation of Ca(2+)-activated K(+) channels contributes to ROS-dependent proliferation of cultured human endothelial cells. J Mol Cell Cardiol 2004, 36:675-682
45. Tarpey MM, Wink DA, Grisham MB: Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004, 286:R431-R444
46. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N: Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 2004, 37:755-767
47. Li Y, Trush MA: Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998, 253:295-299
48. Zmijewski JW, Moellering DR, Le Goffe C, Landar A, Ramachandran A, Darley-Usmar VM: Oxidized low density lipoprotein induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 2005, 289:H852-H861
49. Abas L, Bogoyevitch MA, Guppy M: Mitochondrial ATP production is necessary for activation of the extracellular-signal-regulated kinases during ischaemia/reperfusion in rat myocyte-derived H9c2 cells. Biochem J 2000, 349:119-126
50. Takabe W, Kodama T, Hamakubo T, Tanaka K, Suzuki T, Aburatani H, Matsukawa N, Noguchi N: Anti-atherogenic antioxidants regulate the expression and function of proteasome alpha-type subunits in human endothelial cells. J Biol Chem 2001, 276:40497-40501
51. Smith RA, Porteous CM, Coulter CV, Murphy MP: Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999, 263:709-716
52. Tampo Y, Kotamraju S, Chitambar CR, Kalivendi SV, Keszler A, Joseph J, Kalyanaraman B: Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: role of transferrin receptor-dependent iron uptake in apoptosis. Circ Res 2003, 92:56-63
53. Iles KE, Dickinson DA, Wigley AF, Welty NE, Blank V, Forman HJ: HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic Biol Med 2005, 39:355-364
54. Rogers RJ, Monnier JM, Nick HS: Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J Biol Chem 2001, 276:20419-20427
55. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL: Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 2004, 22:1141-1149
56. Ali MH, Pearlstein DP, Mathieu CE, Schumacker PT: Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 2004, 287:L486-L496
57. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Pastorino AM, Gaviraghi G, Lo Cascio V: Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 1998, 16:1913-1919
58. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T: Activation of stress signaling pathways by the end product of lipid peroxidation: 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999, 274:2234-2242
59. Oka H, Kugiyama K, Doi H, Matsumura T, Shibata H, Miles LA, Sugiyama S, Yasue H: Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. Arterioscler Thromb Vasc Biol 2000, 20:244-250
60. Colles SM, Chisolm GM: Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events. J Lipid Res 2000, 41:1188-1198
61. Tretter L, Adam-Vizi V: Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J Neurosci 2004, 24:7771-7778
62. Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF: Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 2004, 24:7779-7788
63. Lambert AJ, Brand MD: Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 2004, 382:511-517
64. Lambert AJ, Brand MD: Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 2004, 279:39414-39420
65. Usatyuk PV, Natarajan V: Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells. J Biol Chem 2004, 279:11789-11797
66. Noguchi N, Yoshida Y, Kaneda H, Yamamoto Y, Niki E: Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol 1992, 44:39-44
67. Day BJ, Batinic-Haberle I, Crapo JD: Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic Biol Med 1999, 26:730-736
68. Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY: Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001, 104:1519-1525
69. Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, Perrella MA: Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003, 17:1759-1761